Efficacy of a Therapeutic Combination of Dronabinol and PEA for Tourette Syndrome
Status:
Completed
Trial end date:
2018-06-28
Target enrollment:
Participant gender:
Summary
This is an investigator-initiated proof of concept study with the purpose to examine the
safety, tolerability and feasibility of Dronabinol (synthetic Δ9-THC) and PEA for the
treatment of adults with Tourette syndrome.